The Institute for OneWorld Health has discovered that addressing the world’s most menacing health threats sometimes means leaving money on the table. The organization, which is the nation’s first nonprofit pharmaceutical company, develops medications to tackle diseases in the developing world. Because drug development can take as many as 10 years from drawing board to regulatory approval, OneWorld Health has chosen to focus solely on its mission.

After the Asian tsunami, though, wealthy donors...


Want more? Sorry, the full text of this article is only available to subscribers. Subscribe now.

Already a subscriber? Please log in by entering your email address and password into the red login box at the top-right corner of this page.

Need to register for your premium online access, which is included with your paid subscription? Register here.

Tracker Pixel for Entry